Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Recent & Breaking News (GREY:IMVIQ)

IMV Provides an Update on The VITALIZE Trial

Business Wire September 30, 2022

IMV Inc. Announces Strategic Reorganization

Business Wire September 15, 2022

IMV Inc. to Present at Two Investor Conferences in September

Business Wire September 1, 2022

IMV Inc. Announces Second Quarter 2022 Financial and Operational Results

Business Wire August 11, 2022

IMV Re-Establishes Its At-the-Market Facility Under Renewed Base Shelf Prospectus

Business Wire August 5, 2022

IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022

Business Wire August 4, 2022

IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Business Wire July 8, 2022

IMV Announces Annual and Special Meeting of Shareholders Voting Results

Business Wire June 30, 2022

IMV (TSX:IMV) draws down remaining debt facility

Caroline Egan  June 22, 2022

IMV Strengthens Its Financial Position With the $US10 Million Drawdown From Its Existing Long-Term Debt Facility

Business Wire June 22, 2022

IMV Inc. to Present at the H.C. Wainwright Global Investment Conference

Business Wire May 17, 2022

IMV Inc. Announces First Quarter 2022 Financial and Operational Results

Business Wire May 13, 2022

IMV Inc. to Announce First Quarter 2022 Results and Host a Conference Call and Webcast on May 13, 2022

Business Wire May 6, 2022

IMV's Lead Compound to Be Showcased in Two Presentations at the 2022 ASCO Annual Meeting

Business Wire April 28, 2022

IMV Inc. Names Michael P. Bailey Chairman of The Board

Business Wire April 22, 2022

IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting

Business Wire April 8, 2022

IMV to Present at IMMUNOLOGY(TM) 2022, the AAI Annual Meeting

Business Wire April 6, 2022

IMV Inc. to Present at Two Upcoming Investor Conferences

Business Wire April 4, 2022

IMV Inc. Announces Fourth Quarter and Full Year 2021 Financial and Operational Results

Business Wire March 17, 2022

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2021 Results and Host a Conference Call and Webcast on March 17, 2022

Business Wire March 10, 2022